Cardiometabolic Health.
Insulin resistance, ApoB, visceral fat, vitamin D, and the cardiometabolic markers most NZ GP panels miss until it is too late. The earlier markers exist. Reading them in time is what shifts the trajectory.
20 articles in this pillar.
What a Body Composition Scan Actually Tells You: A Christchurch Guide
Bathroom scales report one number that lies. A body composition scan reports six that do not. Lean mass, fat mass, visceral fat, segmental analysis, BMR, water distribution. Each one carries a different read.
BIA vs DEXA Body Composition Scans in NZ: Which One You Actually Need
BIA and DEXA both report body fat and lean mass. They measure different things, cost different amounts, and tell different stories over time. The right one depends on what you are tracking.
The Hidden Nutritional Deficiencies of GLP-1 Use
Reduced food intake means reduced micronutrient intake. These are the deficiencies that develop silently during GLP-1 use and how to prevent them.
Insulin Resistance: Reading the Markers Before You Get the Diagnosis
Insulin resistance moves quietly for ten to fifteen years before HbA1c flags it. By then, much of the damage is set. The earlier markers exist. NZ GPs do not always run them.
The Complete Guide to Metabolic Health for New Zealanders
Metabolic health is the engine underneath weight, energy, mood, and long-term disease risk. Most New Zealanders have no clear read on theirs. Here is what to measure, what moves it, and when to involve your GP.
Continuous Glucose Monitors in New Zealand: What CGM Data Actually Tells You
CGMs landed in NZ pharmacy aisles. The numbers are not the answer. Reading them well is the actual skill.
GLP-1 Medications in New Zealand: What You Need to Know in 2026
The GLP-1 landscape in New Zealand is evolving rapidly. Here is the current state of access, funding, and what it means for your weight management strategy.
Time-Restricted Eating: When the Eating Window Helps and Hurts
Sixteen-eight is a default that does not fit every life. For some clients it sharpens metabolic markers. For others it tanks performance and recovery. The fit is the variable.
Nutrition Timing on GLP-1 Medications: When and What to Eat
When appetite is suppressed, every meal counts. Practical guidance on timing, composition, and prioritisation to maximise nutrition with reduced food volume.
GLP-1 Access in New Zealand: What's Available and What It Costs
Ozempic, Wegovy, Mounjaro: which are available in NZ, what Pharmac funds, and what a private prescription actually costs. Plus the nutrition conversation that should happen alongside, not instead of, the medical one.
GLP-1 Agonists and Gut Health: What Your Prescriber Might Not Tell You
GLP-1 medications profoundly alter gut function. Understanding the digestive implications helps you manage side effects and protect long-term gut health.
Metabolic Flexibility: Why Your Body's Ability to Switch Fuels Matters for Longevity
The ability to efficiently switch between burning carbohydrates and fats is a marker of metabolic health. Most people have lost this flexibility without knowing it.
The GLP-1 Rebound Effect: What Happens When You Stop (and How Nutrition Prevents It)
Studies show most people regain two-thirds of lost weight within a year of stopping GLP-1 medications. Nutrition coaching during treatment is the best insurance policy.
GLP-1 and Exercise Performance: Training Adjustments for Optimal Results
Training on a significant caloric deficit requires adjustments. Here is how to maintain exercise performance and protect lean mass while on GLP-1 medications.
Retatrutide vs Semaglutide vs Tirzepatide: What the Research Actually Shows
Three generations of incretin-based medications, each with different mechanisms. Here is what the clinical data actually shows about efficacy, side effects, and nutritional needs.
Why Your GLP-1 Protocol Needs a Nutrition Strategy (Not Just a Prescription)
A prescription alone is not a strategy. Without structured nutrition, GLP-1 medications can cause as much harm as good through lean mass depletion.
Visceral Fat and ApoB: The Two Markers Most Men Over Fifty Miss
Standard cholesterol panels are insufficient after fifty. Visceral fat and ApoB carry most of the cardiometabolic signal. Here is how to read them and what moves the needle.
How GLP-1 Agonists Work: A Nutritionist's Guide to the Science
GLP-1 receptor agonists have transformed weight management, but understanding their mechanism of action is essential for maximising results through nutrition.
GLP-1 and Muscle Mass: How to Preserve Lean Tissue During Rapid Weight Loss
Rapid weight loss without muscle preservation is a recipe for metabolic decline. Here is how to protect lean tissue while maximising fat loss on GLP-1 medications.
Vitamin D in New Zealand: Why South Islanders Run Low Through Winter
Latitude does not negotiate. From May to August in the South Island, vitamin D synthesis from sun exposure is functionally zero for most people. Most NZ adults are below threshold and do not know.
Stop guessing.
Start seeing.
Take the free metabolic audit. Five minutes. No commitment. You leave with a clear read on where your baseline sits and which programme fits your goals.